Intrinsic Value

The intrinsic value of Chesnara PLC (CSN) under the Base Case is 122.95 GBX per share. Compared with the current market price of 349 GBX, the stock appears Overvalued by 65% .

The intrinsic value is calculated using the DCF method. Net margin recovers from -2.6% last year to 33% by 2031. Revenue grows about -31% a year over the next five years, after falling about 9% a year over the last five years.

Do our valuations actually work? See backtest results .

CSN Intrinsic Value
122.95 GBX
Overvaluation 65%
Intrinsic Value
Price 349 GBX
C

CSN is more expensive than usual. It was this expensive or more expensive on just 3% of days in the past 5 years.

Monitor CSN
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value 98.36
Get notified when the price drops into your buy zone
Current Price 349
Intrinsic Value 122.95
Margin of Safety 20% 98.36
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to CSN

Fundamental Analysis

What Chesnara Does

Insurance Financials

Chesnara PLC is a life and pensions company that buys and runs closed books of insurance and retirement policies. Instead of selling new policies to lots of retail customers, it takes over old portfolios from other insurers and keeps administering them for the long term. Its main business is in the UK, the Netherlands, and Sweden, where it looks after policies that are no longer actively sold but still need claims handling, customer service, and investment management.

Headquarters
United Kingdom UK
Employees
346
IPO date
May 25, 2004
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one CSN stock?

The intrinsic value for Chesnara PLC (CSN) under the Base Case is 122.95 GBX.

Is CSN stock undervalued or overvalued?

Compared with the current market price of 349 GBX, the stock appears Overvalued by 65% .

Back to Top